Invengene Biosciences Private Limited - Company Profile

It is a research & development private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Invengene Biosciences Private Limited

Invengene Biosciences Private Limited, a struck off private limited company, was established on 22 August 2012 in Mumbai, Maharashtra, India. Engaging in science research within the research & development sector, it holds CIN: U73100MH2012PTC234798. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Ankur Janak Shah (Whole-Time Director), Vaibhavi Ankur Shah (Whole-Time Director). Its latest AGM occurred on 29 September 2014, with the balance sheet filed on 31 March 2014. It is based at 30, Saujanya, Vallabh Nagar Soc. N.S. Road No. 3 J.V.P.D. Scheme, Vile Parle West, Mumbai, Maharashtra, 400056.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100MH2012PTC234798

  • Registration Number

    234798

  • Incorporation Date

    22 August 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 6 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Invengene Biosciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Invengene Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Invengene Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Ankur Janak Shah Whole-Time Director 22 Aug 2012 Current
Vaibhavi Ankur Shah Whole-Time Director 22 Aug 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Invengene Biosciences.

Enhance accessibility to Invengene Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Invengene Biosciences revenue growth over time
Invengene Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Invengene Biosciences?

Unlock access to Invengene Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Invengene Biosciences?

Unlock and access historical data on people associated with Invengene Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Invengene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invengene Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Invengene Biosciences
Recent Activity within the Organization
  • Annual General Meeting

    Invengene Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2014 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Invengene Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Ankur Janak Shah was appointed as a Whole-time director was appointed as a Whole-time director on 22 Aug 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Vaibhavi Ankur Shah was appointed as a Whole-time director was appointed as a Whole-time director on 22 Aug 2012 & has been associated with this company since 13 years 6 months . was documented.

  • Company Incorporation

    Invengene Biosciences Private Limited was registered on 22 Aug 2012 with Roc Mumbai & aged 13 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Invengene Biosciences Private Limited?

The CIN of Invengene Biosciences Private Limited is U73100MH2012PTC234798.

Where is Invengene Biosciences Private Limited headquartered?

Invengene Biosciences Private Limited is headquartered at 30, Saujanya, Vallabh Nagar Soc. N.S. Road No. 3 J.V.P.D. Scheme, Vile Parle West, Mumbai, Maharashtra, 400056.

When was Invengene Biosciences Private Limited incorporated?

Invengene Biosciences Private Limited was incorporated on 22 August 2012.

Who are the current directors of Invengene Biosciences Private Limited?

The current directors of Invengene Biosciences Private Limited are

What is the primary industry of Invengene Biosciences Private Limited?

The primary industry of Invengene Biosciences Private Limited is Research & Development.

Is Invengene Biosciences Private Limited a listed company?

Invengene Biosciences Private Limited is unlisted.

What is the capital structure of Invengene Biosciences Private Limited?

The authorized capital of Invengene Biosciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available